Paracetamol Market Report and Forecast 2025-2034
Description
The global paracetamol market size was valued at USD 1.70 Billion in 2024, driven by increasing innovation across the globe. The market size is anticipated to grow at a CAGR of 4.40% during the forecast period of 2025-2034 to achieve a value of USD 2.61 Billion by 2034.
Paracetamol: Introduction
Paracetamol, also known as Panadol, Calpol, or Alvedon, is an analgesic and antipyretic medication that is used to temporarily alleviate mild-to-moderate pain and fever. It is commonly included as an ingredient in cold and flu medications and can also be used individually. Paracetamol and acetaminophen (Tylenol) are the same drugs but they are named differently in different countries. Paracetamol is the name assigned using the International Nonproprietary Name (INN) system, while acetaminophen is the name assigned using the United States Adopted Names (USAN) system. Paracetamol is used in Europe, Australia, New Zealand, and India, while acetaminophen is used in countries such as the United States, Canada, and Japan. Generally, the INN and USAN names for a drug are the same and do not differ between countries.
Global Paracetamol Market Analysis
The global market for paracetamol has experienced significant growth and is poised for steady growth in the coming years as well. The market is poised to grow due to recent developments for example, Dr. Bhaumik Pandya's innovative formulation, aimed at combating liver toxicity associated with paracetamol (PCM), is a significant innovation. By increasing PCM's water solubility, this patented innovation not only enhances safety by preventing liver damage but also enables precise dosing. This will enable patients to take the exact required dosage, such as 250mg, instead of opting for higher doses like 500mg or 650mg, potentially revolutionizing the consumption pattern of paracetamol. This advancement could lead to increased demand for this novel formulation, influencing the global paracetamol market growth.
In August 2023, the market for paracetamol faced a challenge when the prices of its key ingredients suddenly surged. This caught both pharmaceutical companies and healthcare professionals off guard. The unexpected cost escalation could hinder the market growth, leading to either higher retail prices or supply chain disruptions. To mitigate these effects, pharmaceutical companies may need to increase their research and development efforts to create more cost-effective versions of paracetamol. This could stimulate innovation but might also introduce market volatility. Overall, while Dr. Pandya's invention offers a promising way to expand the market and improve patient safety, the increase in ingredient prices presents a hurdle that the industry must overcome to sustain and promise market growth.
Global Paracetamol Market Segmentations
“global paracetamol market and forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Dosage Type
The market has been witnessing significant market growth due to the rising frequency of seasonal flu causing cold and fever coupled with body pain. Paracetamol is used as a primary treatment for mild to moderate cases of fever, headaches, and body pain among others. The rise in frequent cases of fever and cold among the geriatric population, adults, and pediatrics is leading to increased paracetamol market demand.
The convenience of over the counter (OTC) availability of the medication contributes to the increased demand, particularly for common pain and fever relief, adding further value to the paracetamol market share. Paracetamol is often combined with other active ingredients to address multiple symptoms in a single medication (e.g., paracetamol with decongestants for cold relief). Due to the requirement of paracetamol in such combinational dosages, the market is expected to keep expanding for the forecast period.
Global Paracetamol Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Paracetamol: Introduction
Paracetamol, also known as Panadol, Calpol, or Alvedon, is an analgesic and antipyretic medication that is used to temporarily alleviate mild-to-moderate pain and fever. It is commonly included as an ingredient in cold and flu medications and can also be used individually. Paracetamol and acetaminophen (Tylenol) are the same drugs but they are named differently in different countries. Paracetamol is the name assigned using the International Nonproprietary Name (INN) system, while acetaminophen is the name assigned using the United States Adopted Names (USAN) system. Paracetamol is used in Europe, Australia, New Zealand, and India, while acetaminophen is used in countries such as the United States, Canada, and Japan. Generally, the INN and USAN names for a drug are the same and do not differ between countries.
Global Paracetamol Market Analysis
The global market for paracetamol has experienced significant growth and is poised for steady growth in the coming years as well. The market is poised to grow due to recent developments for example, Dr. Bhaumik Pandya's innovative formulation, aimed at combating liver toxicity associated with paracetamol (PCM), is a significant innovation. By increasing PCM's water solubility, this patented innovation not only enhances safety by preventing liver damage but also enables precise dosing. This will enable patients to take the exact required dosage, such as 250mg, instead of opting for higher doses like 500mg or 650mg, potentially revolutionizing the consumption pattern of paracetamol. This advancement could lead to increased demand for this novel formulation, influencing the global paracetamol market growth.
In August 2023, the market for paracetamol faced a challenge when the prices of its key ingredients suddenly surged. This caught both pharmaceutical companies and healthcare professionals off guard. The unexpected cost escalation could hinder the market growth, leading to either higher retail prices or supply chain disruptions. To mitigate these effects, pharmaceutical companies may need to increase their research and development efforts to create more cost-effective versions of paracetamol. This could stimulate innovation but might also introduce market volatility. Overall, while Dr. Pandya's invention offers a promising way to expand the market and improve patient safety, the increase in ingredient prices presents a hurdle that the industry must overcome to sustain and promise market growth.
Global Paracetamol Market Segmentations
“global paracetamol market and forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Dosage Type
- Tablet
- Capsules
- Others
- Headache and Fever
- Cold and Cough
- Muscle Cramps
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market has been witnessing significant market growth due to the rising frequency of seasonal flu causing cold and fever coupled with body pain. Paracetamol is used as a primary treatment for mild to moderate cases of fever, headaches, and body pain among others. The rise in frequent cases of fever and cold among the geriatric population, adults, and pediatrics is leading to increased paracetamol market demand.
The convenience of over the counter (OTC) availability of the medication contributes to the increased demand, particularly for common pain and fever relief, adding further value to the paracetamol market share. Paracetamol is often combined with other active ingredients to address multiple symptoms in a single medication (e.g., paracetamol with decongestants for cold relief). Due to the requirement of paracetamol in such combinational dosages, the market is expected to keep expanding for the forecast period.
Global Paracetamol Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- GlaxoSmithKline plc
- Teva Pharmaceuticals USA, Inc.
- Sanofi
- Mallinckrodt Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- Geno Pharma
- Biological E
- CFL Pharma
- Cipla
- Dr. Reddy’s Lab
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Paracetamol Market Overview
- 3.1 Global Paracetamol Market Historical Value (2018-2024)
- 3.2 Global Paracetamol Market Forecast Value (2025-2034)
- 4 Global Paracetamol Market Landscape
- 4.1 Global Paracetamol: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Paracetamol: Product Landscape
- 4.2.1 Analysis by Dosage Type
- 4.2.2 Analysis by Applications
- 5 Global Paracetamol Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Paracetamol Market Segmentation
- 6.1 Global Paracetamol Market by Dosage Type
- 6.1.1 Market Overview
- 6.1.2 Tablet
- 6.1.3 Capsules
- 6.1.4 Others
- 6.2 Global Paracetamol Market by Applications
- 6.2.1 Market Overview
- 6.2.2 Headache and Fever
- 6.2.3 Cold and Cough
- 6.2.4 Muscle Cramps
- 6.2.5 Others
- 6.3 Global Paracetamol Market by Region
- 6.3.1 Market Overview
- 6.3.2 North America
- 6.3.3 Europe
- 6.3.4 Asia Pacific
- 6.3.5 Latin America
- 6.3.6 Middle East and Africa
- 7 North America Paracetamol Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Paracetamol Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Paracetamol Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Paracetamol Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Paracetamol Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Clinical Trials Analysis
- 15.1 Analysis by Trial Registration Year
- 15.2 Analysis by Trial Status
- 15.3 Analysis by Trial Phase
- 15.4 Analysis by Therapeutic Area
- 15.5 Analysis by Geography
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Partnership and Collaborations Analysis
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 GlaxoSmithKline plc
- 18.1.1 Financial Analysis
- 18.1.2 Product Portfolio
- 18.1.3 Demographic Reach and Achievements
- 18.1.4 Mergers and Acquisitions
- 18.1.5 Certifications
- 18.2 Teva Pharmaceuticals USA, Inc.
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 Sanofi
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Mallinckrodt Pharmaceuticals
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 Sun Pharmaceutical Industries Ltd.
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 Geno Pharma
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 Biological E
- 18.7.1 Product Portfolio
- 18.7.2 Demographic Reach and Achievements
- 18.7.3 Mergers and Acquisitions
- 18.7.4 Certifications
- 18.8 CFL Pharma
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 Cipla
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 Dr. Reddy’s Lab
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
